HomeResearch GuideIntroduction to Peptides: A Comprehensive Guide for Researchers
Back to Research GuideFundamentals

Introduction to Peptides: A Comprehensive Guide for Researchers

Northbridge Research LabsMay 28, 2026 · Updated September 23, 20266 min read
PeptidesPeptide ChemistrySolid-Phase Peptide SynthesisFundamentalsResearch Basics

What peptides are, how the peptide bond and side chains shape their behavior, how research peptides are synthesized and purified, and what that chemistry means for everyday lab work.

Peptides are short chains of amino acids joined by amide bonds, usually called peptide bonds. They sit between single amino acids and full-sized proteins, and that middle position is what makes them so useful in research: they are small enough to be made chemically, one residue at a time, yet large enough to carry the specific shape and charge pattern that lets a hormone find its receptor. This guide covers the chemistry every researcher working with peptides should have in hand, from the bond itself to how a lyophilized research peptide is manufactured, and why those details show up later as questions of solubility, stability and purity.

What Is a Peptide?

A peptide forms when the carboxyl group of one amino acid condenses with the amino group of the next, releasing a molecule of water and leaving an amide link between them. Repeating that step builds a chain with a free amino group at one end, the N-terminus, and a free carboxyl group at the other, the C-terminus. By convention, sequences are written and numbered from the N-terminus to the C-terminus, so Gly-Glu-Pro describes a chain that begins with the free amine of glycine.

Each position in the chain can hold any of the 20 standard amino acids, so the number of possible sequences grows as 20 raised to the chain length: 400 dipeptides, 8,000 tripeptides and more than 10 trillion possible ten-residue peptides. Small changes carry real consequences. Swapping a single residue can change a peptide's charge, its preferred shape, its resistance to enzymes, or whether it binds its target at all.

Peptide or Protein? Where the Line Falls

There is no single agreed cutoff. A common working convention classes chains of roughly 50 residues or fewer as peptides and longer chains as proteins, although textbooks and regulators draw the line in slightly different places. The more useful distinction is structural: most peptides lack the stable, folded tertiary structure that defines a protein, so their behavior is governed by sequence, charge and flexibility rather than by a fixed three-dimensional fold.

  • Dipeptides: two residues (for example carnosine, beta-alanyl-L-histidine)
  • Tripeptides: three residues (for example glutathione and GHK)
  • Oligopeptides: short chains, commonly up to about 20 residues
  • Polypeptides: longer chains, commonly up to about 50 residues
  • Proteins: longer chains, usually with a defined folded structure

The Peptide Bond and the Backbone

The amide bond has partial double-bond character because the lone pair on the nitrogen is shared with the neighboring carbonyl group. That holds the atoms around each bond in a flat plane, almost always in the trans arrangement, so the backbone can rotate only at the two single bonds on either side of each alpha carbon. Those two rotation angles, repeated along the chain, define every shape a peptide can adopt.

Hydrogen bonds between backbone N-H and C=O groups stabilize recurring shapes. In 1951, Pauling, Corey and Branson used the planar geometry of the amide group to propose two hydrogen-bonded helical configurations for the polypeptide chain, one of which became known as the alpha-helix [1]. Beta-strands, sheets and turns complete the common set of secondary structures. Many short peptides are flexible in water and only take on a defined helix or turn when they meet a membrane or a receptor, which is one reason the same peptide can look disordered in one experiment and structured in another.

Side Chains Decide How a Peptide Behaves

The backbone is the same for every peptide; the side chains are not. They drive nearly every practical property a researcher notices at the bench:

  • Charge: lysine, arginine and histidine carry positive charge, aspartate and glutamate carry negative charge, and the balance of the two, together with the free termini, sets the net charge at a given pH. Net charge is one of the strongest predictors of how easily a peptide dissolves in water.
  • Hydrophobicity: sequences rich in leucine, isoleucine, valine, phenylalanine or tryptophan tend to resist dissolving in water and may need a small amount of organic co-solvent first.
  • Reactivity: cysteine can form disulfide bonds, methionine and tryptophan are prone to oxidation, and asparagine and glutamine can deamidate over time. These are the residues to watch in storage.
  • Conformation: proline restricts backbone rotation and often introduces turns, while glycine, with no side chain at all, allows unusual flexibility.

Our guide to peptide storage and handling builds directly on these points.

Beyond the Standard Twenty: Modifications

Natural and synthetic peptides often carry chemical changes that are not part of the plain amino acid sequence. Ghrelin is a well-known natural example. When it was first identified in 1999, the 28-residue hormone was found to carry an n-octanoyl group on the serine at position 3, and that acyl group was essential for its growth hormone-releasing activity [2]. Synthetic research peptides use modifications deliberately. A growth hormone-releasing hexapeptide described in 1984, later known as GHRP-6, has the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2, combining two D-amino acids with an amidated C-terminus [3].

Modifications you will meet on research peptide specification sheets include:

  • C-terminal amidation, which removes the negative charge at the C-terminus and is common among peptide hormones
  • N-terminal acetylation, which removes the positive charge at the N-terminus
  • D-amino acids, which many proteases do not recognize
  • Cyclization, including disulfide bridges between cysteine residues
  • Fatty-acid chains or other groups designed to bind serum albumin
  • Metal complexes, as in the copper complex of GHK

Each of these changes the molecular weight, and several change the net charge, so they need to be accounted for when calculating concentrations or predicting solubility.

How Research Peptides Are Made

Almost all research peptides are produced by solid-phase peptide synthesis (SPPS), the method R. B. Merrifield introduced in 1963 with the synthesis of a tetrapeptide [4]. The first amino acid is anchored by its C-terminus to an insoluble resin, and the chain is built toward the N-terminus one residue at a time: remove the temporary protecting group, couple the next protected amino acid, wash, and repeat. Because the growing chain stays attached to the resin, excess reagents can simply be washed away, which is what made the approach fast and general enough to become the standard.

No step is perfect, and small inefficiencies compound over a long sequence. A review of related impurities in peptide medicines describes the typical by-products of SPPS: deletion sequences missing a residue after an incomplete deprotection, insertions caused by excess amino acid reagent, racemized residues, side chains that kept a protecting group, oxidized forms, dimers, and trifluoroacetate counter-ions carried over from synthesis and purification [5]. After the finished chain is cleaved from the resin, the crude product is purified, most often by reversed-phase HPLC, and freeze-dried into the white, fluffy solid most researchers recognize.

This is why a research peptide arrives as a salt with some residual water, and why a purity figure and the amount of actual peptide in the vial are two different numbers. Our guide to understanding peptide purity covers that distinction in detail.

Why Peptides Matter in Research

Peptides carry a remarkable share of the body's signaling. They act as hormones, neurotransmitters, growth factors and antimicrobial defenses, and that biological reach has made them a durable source of medicines. Insulin, introduced in the 1920s, was the first peptide therapeutic; a 2018 review counted more than 60 peptide drugs approved in the United States and other major markets [6], and a 2021 perspective in Nature Reviews Drug Discovery put the number that have reached the market at more than 80 [7].

Writing from inside the pharmaceutical industry, Fosgerau and Hoffmann described peptides as highly selective, efficacious and relatively well tolerated, and noted that approximately 140 peptide therapeutics were in clinical trials at the time of their 2015 review [8]. The same review lays out the familiar weaknesses: short half-life, rapid clearance, low oral bioavailability and limited ability to cross physiological barriers [8]. Much of modern peptide chemistry, including the modifications described above, is an effort to keep the selectivity while working around those limits.

In the laboratory, peptides are used to:

  • Map receptor-ligand interactions and structure-activity relationships, one residue at a time
  • Probe signaling pathways with defined agonists and antagonists
  • Study enzyme specificity with peptide substrates and inhibitors
  • Model tissue repair, metabolic regulation and endocrine feedback in cell and animal systems
  • Raise and characterize antibodies against defined epitopes

What This Means at the Bench

The chemistry above translates into a few habits that make peptide experiments more reproducible. Know the full sequence, including terminal modifications, so you can predict charge and solubility. Know which residues are prone to oxidation or deamidation so you can store the material accordingly. Know the counter-ion and net peptide content so that calculated concentrations reflect peptide rather than salt and water. And record the lot number used in every experiment, because two batches of the same sequence can differ in their impurity profile.

Note: All peptides sold by Northbridge Research Labs are intended for laboratory research use only. They are not for human or veterinary use.

Key Research References

  1. Pauling L, Corey RB, Branson HR. The structure of proteins; two hydrogen-bonded helical configurations of the polypeptide chain. Proceedings of the National Academy of Sciences of the United States of America. 1951;37:205-211. doi:10.1073/pnas.37.4.205
  2. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660. doi:10.1038/45230
  3. Bowers CY, Momany FA, Reynolds GA, et al. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114:1537-1545. doi:10.1210/endo-114-5-1537
  4. Merrifield RB. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society. 1963;85:2149-2154. doi:10.1021/ja00897a025
  5. D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis. 2014;101:2-30. doi:10.1016/j.jpba.2014.06.012
  6. Lau JL, Dunn MK. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry. 2018;26:2700-2707. doi:10.1016/j.bmc.2017.06.052
  7. Muttenthaler M, King GF, Adams DJ, et al. Trends in peptide drug discovery. Nature Reviews Drug Discovery. 2021;20:309-325. doi:10.1038/s41573-020-00135-8
  8. Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discovery Today. 2015;20:122-128. doi:10.1016/j.drudis.2014.10.003
Share this article:

Research Use Only: The information in this article is for educational and research purposes only. All products mentioned are intended for laboratory research use only and are not approved for human or veterinary use.